PNPLA3 and metabolic dysfunction-associated steatotic liver disease: Numerous studies across diverse ethnicities have confirmed its strong association with increased hepatic fat content, NASH, and fibrosis, making PNPLA3 a robust genetic marker for MASLD progression [8,9].